CtDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer
Ontology highlight
ABSTRACT: By monitoring the serum ctDNA mutational profile using NGS, the present clinical trial aims to elucidate the correlation between the postoperative ctDNA status and the prognosis of patients with early and intermediate-stage colorectal cancer, and explore the possibility of clinical utility of serum ctDNA as a clinical index to predict postoperative relapse.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2256602 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA